Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Mar'24
Net Sales
145.35
152.06
Other Operating Income
0.00
0.00
Total Operating income
145.35
152.06
Raw Material Cost
40.39
35.08
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
Employee Cost
0.00
0.00
Power Cost
0.00
0.00
Manufacturing Expenses
0.61
0.21
Selling and Distribution Expenses
64.06
80.94
Other Expenses
3.12
3.27
Total Expenditure (Excl Depreciation)
136.30
148.93
Operating Profit (PBDIT) excl Other Income
9
3.1
Other Income
1.99
0.91
Operating Profit (PBDIT)
28.45
18.77
Interest
0.61
0.21
Exceptional Items
1.80
2.12
Gross Profit (PBDT)
104.95
116.98
Depreciation
17.42
14.73
Profit Before Tax
12.22
5.96
Tax
-1.48
-0.75
Provisions and contingencies
0.00
0.00
Profit After Tax
13.70
6.69
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
13.70
6.69
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
13.70
6.69
Equity Capital
0.00
0.00
Face Value
1.07
1.08
Reserves
1,028.62
0.00
Earnings per share (EPS)
0.03
0.02
Diluted Earnings per share
0.03
0.02
Operating Profit Margin (Excl OI)
6.22%
2.06%
Gross Profit Margin
20.39%
13.61%
PAT Margin
9.43%
4.4%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Analysis not available
Compare Quarterly Results Of CF PharmTech, Inc With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
145.35
0
145.35
Other Operating Income
0.00
0.00
0.00
Total Operating income
145.35
0
145.35
Raw Material Cost
40.39
0
40.39
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.61
0
0.61
Selling and Distribution Expenses
64.06
0
64.06
Other Expenses
3.12
0.00
3.12
Total Expenditure (Excl Depreciation)
136.30
0
136.30
Operating Profit (PBDIT) excl Other Income
9.04
0.00
9.04
Other Income
1.99
0
1.99
Operating Profit (PBDIT)
28.45
0
28.45
Interest
0.61
0
0.61
Exceptional Items
1.80
0
1.80
Gross Profit (PBDT)
104.95
0
104.95
Depreciation
17.42
0
17.42
Profit Before Tax
12.22
0
12.22
Tax
-1.48
0
-1.48
Provisions and contingencies
0
0
0.00
Profit After Tax
13.70
0
13.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
13.70
0
13.70
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13.70
0
13.70
Equity Capital
0
0
0.00
Face Value
1.07
0
0.00
Reserves
1,028.62
0
1,028.62
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
6.22%
0%
0.00
6.22%
Gross Profit Margin
20.39%
0%
0.00
20.39%
PAT Margin
9.43%
0%
0.00
9.43%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in Figures in Million
Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in Figures in Million
Quarterly - Interest
Interest NA Million
in Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in Figures in %






